SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-010273
Filing Date
2018-04-17
Accepted
2018-04-17 16:45:24
Documents
2
Period of Report
2018-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2255
2 EX-24 DOCUMENT attachment1.htm EX-24 4414
  Complete submission text file 0000899243-18-010273.txt   8025
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SECOND AVENUE, SUITE 4200 SEATTLE WA 98101
Business Address
SCHEIBLER LUKAS (Reporting) CIK: 0001651281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 18759434